Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices
Farrah J. Mateen, Shawheen J. Rezaei, Nicholas Alakel, Brittany Gazdag, Aditya Kumar, Andre C. Vogel
Topics & Concepts
MedicineNatalizumabAlemtuzumabWorryMultiple sclerosisCoronavirus disease 2019 (COVID-19)NeurologyFingolimodFamily medicineEmergency medicinePediatricsInternal medicineAnxietyPsychiatryTransplantationInfectious disease (medical specialty)DiseaseMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research